Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells

Food and Chemical Toxicology

Volumn 37, Issue 4, 1999, Pages 319-326

  Chung, J G ^a   Wu, L T ^a   Chu, C B ^a   Jan, J Y ^a   Ho, C C ^a   Tsou, M F ^b   Lu, H F ^b   Chen, G W ^a   Lin, J G ^a   Wang, T F ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

2 Aminofluorene; Berberine; Human bladder cell; N acetyl 2 aminofluorene; N acetyl p aminobenzoic acid; N acetyltransferase; p aminobenzoic

Indexed keywords

2 FLUORENYLAMINE; 4 AMINOBENZOIC ACID; ARYLAMINE ACETYLTRANSFERASE; BERBERINE; N (2 FLUORENYL)ACETAMIDE;

ARTICLE; BLADDER CANCER; CELL SUSPENSION; CONTROLLED STUDY; CYTOSOL; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MICHAELIS CONSTANT;

4-AMINOBENZOIC ACID; ARYLAMINE N-ACETYLTRANSFERASE; BERBERINE; CARCINOGENS; ENZYME INHIBITORS; FLUORENES; HUMANS; KINETICS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032785646     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(99)00016-2     Document Type: Article

References (29)

1. Amin A.H., Subbaiah T.V., Abbasi K.M. Berberine sulfate: antimicrobial activity, bioassay and mode of action. Canadian Journal of Microbiology. 15:1969;1067-1076.
2. Berlin G., Enerback L. Fluorescent berberine binding as a marker of secretory activity in mast cells. International Archives of Allergy and Applied Immunology. 71:1983;332-339.
3. Beland F.A., Beranek D.T., Dooley K.L., Helflich R.H., Kadlubar F.F. Arylamine-DNA adducts in vitro and in vivo: Their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environmental Health Perspectives. 49:1983;125-134.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
5. Cartwright R.A., Glasham R.W., Rogers H.J., Ahmed R.A., Barham-Hall D., Higgens E., Kahn M.A. Role of N-acetyltransferase phenotype in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet. ii:1982;842-846.
6. Chung J.G., Levy G.N., Weber W.W. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6. A-Nats slow acetylator congenic mice. Drug Metabolism and Disposition. 21:1993;1057-1063.
7. Chung J.G., Wang W.W., Chen G.W., Wu L.T., La J.M., Tsai C.H. Kinetics of arylamine N-acetyltransferase in tissues from human colon tumour. Medical Journal of the CMCH. 2:1997;81-92.
8. Ckless K., Schlotiffldt J.L., Pasoqual M., Moyna P., Henriques J.A.P., Wajner M. Inhibition of In-vitro lymphocyte transformation by the isoquinoline alkaloid berberine. Journal of Pharmacy and Pharmacology. 47:1995;1029-1031.
9. Cleland W.W. The statistical analysis of enzyme kinetic data. Advances in Enzymology. 29:1967;1-32.
10. Einisto P., Watanabe M., Ishidate M., Nohmi T. Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Research. 259:1991;95-102.
11. Flammang T. J., Hein D. W., Talaska G. and Kadlubar F. F. (1988) N-hydroxyarylamine O-acetyltransferase and its relationship to aromatic amine N-acetyltransferase polymorphism in the inbred hamster and in human tissue cytosol. In Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, ed. C. King, D. Schuetzle and L. Romano, pp. 137-148. Elsevier, New York.
12. Glowinski I.B., Radtke H.E., Weber W.W. Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver. Molecular Pharmacology. 14:1978;940-949.
13. Grant D.M., Blum M., Beer M., Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferase: A comparison of liver isozymes and expressed products of two cloned genes. Molecular Pharmacology. 39:1991;184-191.
14. Guandalini S., Fasano A., Migliavacca M., Marchesano A. F. and Rubino A. (19??) Effects of berberine on basal and secret agogue-modified ion transport in the rabbit ileum in vitro. Journal of Pediatriatric Gastroenterology 6, 953-960.
15. Hickman D., Sim E. N-acetyltransferase polymorphism: Comparison of phenotype and genotype in human. Biochemical Pharmacology. 42:1991;1007-1014.
16. Hoshi A., Ikekawa T., Ikeda Y., Shirakawa S., Ligo M., Kuretani K., Fukoka F. Antitumour activity of berberubine derivatives. Gann. 67:1976;321-325.
17. Ilett K.F., David B.M., Detchon P., Castledon W., Kwa R. Acetylator phenotype in colorectal carcinoma. Cancer Research. 47:1987;1466-1469.
18. Kirlin W., Gandrews A., Ogolla F., Yerokun T., Ferguson R.J., Hein D.W. Comparison of the polymorphic expression of N-acetyltransferase activity in human colon and bladder cytosol. Proceedings of the American Association for Cancer Research. 30:1989;160-166.
19. Kirlin W.G., Trinidad A., Yerokun T., Ogolla F., Ferguson R.J., Andrews A.F., Brady P.K., Hein D.W. Polymorphic expression of AcCoA-dependent arylamine N-acetyltransferase and AcCoA-dependent O-acetyltransferase activation of N-hydroxyarylamine by human bladder cytosol. Cancer Research. 49:1989;2448-2454.
20. Lang N.P., Chu D.Z.J., Hunter C.F., Kendall D.C., Flammang T.J., Kadlubar F.F. Role of aromatic amine acetyltransferase in human colorectal cancer. Archives of Surgery. 121:1986;1259-1261.
21. Lower G.M. Jr, Nilsson T., Nelson C.E., Wolf H., Gamsky T.E., Bryan G.T. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives. 29:1979;71-79.
22. Parker H. G. and Evans A. E. Z. (1984) Epidemiology of aromatic amine cancers. In Chemical Carcinogens, ed. C. E. Searle, 2nd edn, pp. 277-302. ACS Monograph 182. American Chemical Society, Washington, DC.
23. Tai Y.H., Feser J.F., Marnane W.G., Desjeux J.F. Antisecretory effects of berberine in rat ileum. American Journal of Physiology. 241:1981;G253-G258.
24. Tang W. and Eisenbrand G. (1992) Chinese Drugs of Plant Origin, pp. 361-371. Springer, London.
25. Taylor C.T., Baird A.W. Berberine inhibits electrogenic chloride secretion in rat colon in vitro. British Journal of Pharmacology. 110:1993;129.
26. Weber W. W. (1987) The Acetylator Genes and Drug Response, pp. 21-55. Oxford University Press, New York.
27. Weber W.W., Hein D.W. N-acetylation pharmacogenetics. Pharmacological Review. 37:1985;25-79.
28. Yamamoto K., Takase H., Abe K., Saito K., Suzuki A. Pharmacological studies on anti-diarrheal effects of a preparation containing berberine and Gerainin herba. Nippon Yakurigaku Zasshi. 101:1993;169-175.
29. Zhang R.X. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumours. Chinese Medical Journal. 103:1990;658-665.